CoChat

New Therapies for Diabetic Kidney Disease

Himmelfarb, Jonathan, Tuttle, Katherine R. · 2013 · New England Journal of Medicine
Cited by 84

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Fueled by a global pandemic of obesity, diabetic kidney disease is a pressing public health challenge. Diabetic kidney disease is the most common cause of chronic kidney disease, leading to premature death and end-stage renal disease (ESRD) in the developed and developing worlds. Remarkably, the excess risk of death from any cause in type 1 or 2 diabetes is associated almost entirely with the presence of kidney disease. In the absence of diabetic kidney disease, the risk of death among persons with diabetes is similar to that in the general population.1,2 The management of diabetic kidney disease focuses on . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejme1313104

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 84

Metadata

Authors
Himmelfarb, J., & Tuttle, K. R.
Venue
New England Journal of Medicine
Published
2013-12-26
Volume
369
Issue
26
Pages
2549-2550
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4252140613
Cited by
84
References
6
FWCI
7.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Therapies for Diabetic Kidney Disease. https://app.cochat.ai/papers/10.1056/nejme1313104
The paper
Himmelfarb, J., & Tuttle, K. R. (2013). New Therapies for Diabetic Kidney Disease. New England Journal of Medicine. https://doi.org/10.1056/nejme1313104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.